annual net income:
-$599.49M-$394.22M(-192.04%)Summary
- As of today (June 22, 2025), ARWR annual net profit is -$599.49 million, with the most recent change of -$394.22 million (-192.04%) on September 30, 2024.
- During the last 3 years, ARWR annual net income has fallen by -$458.64 million (-325.63%).
- ARWR annual net income is now -981.93% below its all-time high of $67.97 million, reached on September 30, 2019.
Performance
ARWR Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$370.44M+$543.53M(+314.02%)Summary
- As of today (June 22, 2025), ARWR quarterly net profit is $370.44 million, with the most recent change of +$543.53 million (+314.02%) on March 31, 2025.
- Over the past year, ARWR quarterly net income has increased by +$495.75 million (+395.65%).
- ARWR quarterly net income is now at all-time high.
Performance
ARWR quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$143.97M+$495.75M(+77.49%)Summary
- As of today (June 22, 2025), ARWR TTM net profit is -$143.97 million, with the most recent change of +$495.75 million (+77.49%) on March 31, 2025.
- Over the past year, ARWR TTM net income has increased by +$326.82 million (+69.42%).
- ARWR TTM net income is now -311.80% below its all-time high of $67.98 million, reached on September 30, 2019.
Performance
ARWR TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ARWR Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -192.0% | +395.6% | +69.4% |
| 3 y3 years | -325.6% | +735.0% | -28.8% |
| 5 y5 years | -981.9% | +1967.5% | -1610.4% |
ARWR Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -325.6% | at low | at high | +314.0% | -28.8% | +77.5% |
| 5 y | 5-year | -981.9% | at low | at high | +314.0% | -1610.4% | +77.5% |
| alltime | all time | -981.9% | at low | at high | +314.0% | -311.8% | +77.5% |
ARWR Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $370.44M(-314.0%) | -$143.97M(-77.5%) |
| Dec 2024 | - | -$173.09M(+1.5%) | -$639.71M(+6.7%) |
| Sep 2024 | -$599.49M(+192.0%) | -$170.54M(-0.2%) | -$599.49M(+11.3%) |
| Jun 2024 | - | -$170.79M(+36.3%) | -$538.64M(+14.4%) |
| Mar 2024 | - | -$125.30M(-5.7%) | -$470.79M(+58.6%) |
| Dec 2023 | - | -$132.86M(+21.1%) | -$296.81M(+44.6%) |
| Sep 2023 | -$205.28M(+16.6%) | -$109.68M(+6.5%) | -$205.28M(+13.3%) |
| Jun 2023 | - | -$102.95M(-311.5%) | -$181.11M(+20.6%) |
| Mar 2023 | - | $48.67M(-217.8%) | -$150.21M(-2.8%) |
| Dec 2022 | - | -$41.33M(-51.7%) | -$154.52M(-12.2%) |
| Sep 2022 | -$176.06M(+25.0%) | -$85.51M(+18.7%) | -$176.06M(+14.4%) |
| Jun 2022 | - | -$72.05M(-262.4%) | -$153.93M(+37.7%) |
| Mar 2022 | - | $44.37M(-170.6%) | -$111.80M(-38.9%) |
| Dec 2021 | - | -$62.87M(-0.8%) | -$182.99M(+29.9%) |
| Sep 2021 | -$140.85M(+66.6%) | -$63.37M(+111.8%) | -$140.85M(+11.9%) |
| Jun 2021 | - | -$29.92M(+11.6%) | -$125.91M(+14.9%) |
| Mar 2021 | - | -$26.82M(+29.4%) | -$109.59M(+6.8%) |
| Dec 2020 | - | -$20.73M(-57.2%) | -$102.61M(+21.4%) |
| Sep 2020 | -$84.55M(-224.4%) | -$48.43M(+255.8%) | -$84.55M(+246.3%) |
| Jun 2020 | - | -$13.61M(-31.4%) | -$24.41M(-356.1%) |
| Mar 2020 | - | -$19.84M(+642.1%) | $9.53M(-82.1%) |
| Dec 2019 | - | -$2.67M(-122.8%) | $53.26M(-21.6%) |
| Sep 2019 | $67.97M(-224.8%) | $11.71M(-42.4%) | $67.98M(+49.4%) |
| Jun 2019 | - | $20.34M(-14.9%) | $45.51M(+375.7%) |
| Mar 2019 | - | $23.90M(+98.5%) | $9.57M(-132.7%) |
| Dec 2018 | - | $12.04M(-211.9%) | -$29.21M(-46.3%) |
| Sep 2018 | -$54.45M(+58.4%) | -$10.76M(-31.0%) | -$54.45M(+0.1%) |
| Jun 2018 | - | -$15.61M(+4.8%) | -$54.42M(+22.8%) |
| Mar 2018 | - | -$14.88M(+12.8%) | -$44.33M(+24.9%) |
| Dec 2017 | - | -$13.20M(+23.0%) | -$35.49M(+3.2%) |
| Sep 2017 | -$34.38M(-57.9%) | -$10.73M(+94.4%) | -$34.38M(-25.0%) |
| Jun 2017 | - | -$5.52M(-8.7%) | -$45.87M(-23.3%) |
| Mar 2017 | - | -$6.04M(-50.0%) | -$59.77M(-19.8%) |
| Dec 2016 | - | -$12.09M(-45.6%) | -$74.54M(-8.8%) |
| Sep 2016 | -$81.72M(-11.1%) | -$22.22M(+14.4%) | -$81.72M(-3.0%) |
| Jun 2016 | - | -$19.42M(-6.7%) | -$84.24M(+4.3%) |
| Mar 2016 | - | -$20.82M(+8.1%) | -$80.76M(-8.9%) |
| Dec 2015 | - | -$19.26M(-22.1%) | -$88.63M(-3.6%) |
| Sep 2015 | -$91.94M(+56.8%) | -$24.74M(+55.3%) | -$91.94M(+2.6%) |
| Jun 2015 | - | -$15.94M(-44.4%) | -$89.63M(+5.0%) |
| Mar 2015 | - | -$28.68M(+27.1%) | -$85.32M(+20.9%) |
| Dec 2014 | - | -$22.58M(+0.6%) | -$70.58M(+20.4%) |
| Sep 2014 | -$58.63M(+88.3%) | -$22.43M(+92.9%) | -$58.63M(+17.5%) |
| Jun 2014 | - | -$11.63M(-16.6%) | -$49.89M(+12.5%) |
| Mar 2014 | - | -$13.94M(+31.2%) | -$44.34M(+19.3%) |
| Dec 2013 | - | -$10.63M(-22.4%) | -$37.16M(+19.3%) |
| Sep 2013 | -$31.14M(+47.4%) | -$13.69M(+125.2%) | -$31.14M(+36.8%) |
| Jun 2013 | - | -$6.08M(-10.0%) | -$22.76M(-7.8%) |
| Mar 2013 | - | -$6.76M(+46.5%) | -$24.68M(+6.1%) |
| Dec 2012 | - | -$4.61M(-13.2%) | -$23.25M(+10.1%) |
| Sep 2012 | -$21.13M | -$5.31M(-33.5%) | -$21.13M(+13.6%) |
| Jun 2012 | - | -$7.99M(+49.8%) | -$18.59M(+49.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$5.34M(+114.7%) | -$12.42M(+197.3%) |
| Dec 2011 | - | -$2.49M(-10.5%) | -$4.18M(+33.5%) |
| Sep 2011 | -$3.13M(-45.8%) | -$2.78M(+52.6%) | -$3.13M(+32.8%) |
| Jun 2011 | - | -$1.82M(-162.6%) | -$2.36M(+159.6%) |
| Mar 2011 | - | $2.91M(-302.1%) | -$907.70K(-84.0%) |
| Dec 2010 | - | -$1.44M(-28.3%) | -$5.67M(-1.9%) |
| Sep 2010 | -$5.77M(-70.1%) | -$2.00M(+440.0%) | -$5.77M(-20.1%) |
| Jun 2010 | - | -$371.10K(-80.0%) | -$7.23M(-23.0%) |
| Mar 2010 | - | -$1.85M(+20.0%) | -$9.39M(-26.8%) |
| Dec 2009 | - | -$1.54M(-55.3%) | -$12.82M(-33.6%) |
| Sep 2009 | -$19.31M(-28.7%) | -$3.46M(+36.8%) | -$19.31M(-21.2%) |
| Jun 2009 | - | -$2.53M(-52.2%) | -$24.51M(-16.9%) |
| Mar 2009 | - | -$5.29M(-34.1%) | -$29.48M(-1.4%) |
| Dec 2008 | - | -$8.03M(-7.3%) | -$29.89M(+10.3%) |
| Sep 2008 | -$27.09M(-9.5%) | -$8.66M(+15.4%) | -$27.09M(+4.2%) |
| Jun 2008 | - | -$7.50M(+31.7%) | -$26.00M(-16.1%) |
| Mar 2008 | - | -$5.69M(+8.8%) | -$30.98M(-1.5%) |
| Dec 2007 | - | -$5.23M(-30.9%) | -$31.46M(+5.1%) |
| Sep 2007 | -$29.93M(+57.6%) | -$7.57M(-39.3%) | -$29.93M(+4.1%) |
| Jun 2007 | - | -$12.48M(+102.1%) | -$28.76M(+41.0%) |
| Mar 2007 | - | -$6.17M(+66.5%) | -$20.40M(+5.0%) |
| Dec 2006 | - | -$3.71M(-42.1%) | -$19.42M(+3.0%) |
| Sep 2006 | -$19.00M(+177.1%) | -$6.41M(+55.8%) | -$18.85M(+23.1%) |
| Jun 2006 | - | -$4.11M(-20.9%) | -$15.32M(+8.1%) |
| Mar 2006 | - | -$5.19M(+65.6%) | -$14.17M(+69.5%) |
| Dec 2005 | - | -$3.14M(+9.2%) | -$8.36M(+23.2%) |
| Sep 2005 | -$6.85M(+171.1%) | -$2.87M(-3.1%) | -$6.79M(+25.2%) |
| Jun 2005 | - | -$2.97M(-581.5%) | -$5.42M(+75.3%) |
| Mar 2005 | - | $615.90K(-139.4%) | -$3.09M(-20.4%) |
| Dec 2004 | - | -$1.56M(+3.6%) | -$3.88M(+53.7%) |
| Sep 2004 | -$2.53M(+2555.7%) | -$1.51M(+136.3%) | -$2.53M(+177.2%) |
| Jun 2004 | - | -$638.20K(+262.8%) | -$911.90K(+178.7%) |
| Mar 2004 | - | -$175.90K(-14.6%) | -$327.20K(+27.8%) |
| Dec 2003 | - | -$205.90K(-290.5%) | -$256.10K(+168.7%) |
| Sep 2003 | -$95.20K(-61.3%) | $108.10K(-302.1%) | -$95.30K(-66.9%) |
| Jun 2003 | - | -$53.50K(-49.0%) | -$288.10K(-10.7%) |
| Mar 2003 | - | -$104.80K(+132.4%) | -$322.70K(+41.5%) |
| Dec 2002 | - | -$45.10K(-46.8%) | -$228.10K(-7.4%) |
| Sep 2002 | -$246.20K(+32.5%) | -$84.70K(-3.9%) | -$246.30K(+10.7%) |
| Jun 2002 | - | -$88.10K(+763.7%) | -$222.50K(+33.2%) |
| Mar 2002 | - | -$10.20K(-83.9%) | -$167.00K(-19.8%) |
| Dec 2001 | - | -$63.30K(+3.9%) | -$208.20K(+12.1%) |
| Sep 2001 | -$185.80K(+35.0%) | -$60.90K(+86.8%) | -$185.70K(+106.3%) |
| Jun 2001 | - | -$32.60K(-36.6%) | -$90.00K(-21.7%) |
| Mar 2001 | - | -$51.40K(+26.0%) | -$115.00K(-2.3%) |
| Dec 2000 | - | -$40.80K(-217.2%) | -$117.70K(-14.5%) |
| Sep 2000 | -$137.60K(-123.2%) | $34.80K(-160.4%) | -$137.60K(-20.2%) |
| Jun 2000 | - | -$57.60K(+6.5%) | -$172.40K(+50.2%) |
| Mar 2000 | - | -$54.10K(-10.9%) | -$114.80K(+89.1%) |
| Dec 1999 | - | -$60.70K | -$60.70K |
| Sep 1999 | $593.00K(-459.4%) | - | - |
| Sep 1998 | -$165.00K(-80.7%) | - | - |
| Sep 1997 | -$854.50K | - | - |
FAQ
- What is Arrowhead Pharmaceuticals annual net profit?
- What is the all time high annual net income for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual net income year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly net income year-on-year change?
- What is Arrowhead Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals TTM net income year-on-year change?
What is Arrowhead Pharmaceuticals annual net profit?
The current annual net income of ARWR is -$599.49M
What is the all time high annual net income for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual net profit is $67.97M
What is Arrowhead Pharmaceuticals annual net income year-on-year change?
Over the past year, ARWR annual net profit has changed by -$394.22M (-192.04%)
What is Arrowhead Pharmaceuticals quarterly net profit?
The current quarterly net income of ARWR is $370.44M
What is the all time high quarterly net income for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly net profit is $370.44M
What is Arrowhead Pharmaceuticals quarterly net income year-on-year change?
Over the past year, ARWR quarterly net profit has changed by +$495.75M (+395.65%)
What is Arrowhead Pharmaceuticals TTM net profit?
The current TTM net income of ARWR is -$143.97M
What is the all time high TTM net income for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high TTM net profit is $67.98M
What is Arrowhead Pharmaceuticals TTM net income year-on-year change?
Over the past year, ARWR TTM net profit has changed by +$326.82M (+69.42%)